Raytheon Completes Guided Flight Test of Seagriffin Missile with Dual-Mode Seeker

Raytheon Company successfully completed the latest guided flight test of its SeaGriffin™ missile.

The test further demonstrated the effectiveness of SeaGriffin's semi-active laser guidance system, and the missile's ability to capture images from a newly-added imaging infrared seeker (IIR).

During the Raytheon-funded test, a SeaGriffin missile, launched from an integrated surface launch system, provided streaming video from its IIR seeker through an on-board datalink. Command and Control operators could use the datalink for target verification before the missile strikes a small boat target.

"In busy littoral waters, target discrimination is critical so friendly ships aren't mistakenly engaged," said Dr. Thomas R. Bussing, vice president of Advanced Missile Systems at Raytheon. "Raytheon is developing SeaGriffin with a dual-mode seeker to give our warfighters the target discrimination and accuracy they need for countering swarming boat threats in this high-traffic environment. We are also working to significantly extend its range to meet Navy requirements."

Raytheon is conducting a series of SeaGriffin guided flight tests to demonstrate the missile's readiness as the Surface Warfare solution for U.S. Navy's Littoral Combat Ships Surface-to-Surface Missile Module. The latest test follows the successful demonstration of SeaGriffin's extended range capability in late 2013 when the missile successfully navigated away from the target, then flew to and struck the target well beyond Griffin's operational range.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.